Nutriband (Nutriband) EBIT per Share : $-0.68 (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Nutriband EBIT per Share?

Nutriband's EBIT per Share for the three months ended in Jan. 2024 was $-0.22. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.68.

During the past 3 years, the average EBIT per Share Growth Rate was -16.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Nutriband's EBIT per Share or its related term are showing as below:

NTRB' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -131.8 Med: -16.7 Max: 2.4
Current: -16.7

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Nutriband was 2.40% per year. The lowest was -131.80% per year. And the median was -16.70% per year.

NTRB's 3-Year EBIT Growth Rate is ranked worse than
72.41% of 1305 companies
in the Biotechnology industry
Industry Median: 3.6 vs NTRB: -16.70

Nutriband's EBIT for the three months ended in Jan. 2024 was $-1.86 Mil.

Nutriband EBIT per Share Historical Data

The historical data trend for Nutriband's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband EBIT per Share Chart

Nutriband Annual Data

Trend

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

EBIT per Share

Get a 7-Day Free Trial

-0.42

-0.39

-0.76

-0.53

-0.68

Nutriband Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBIT per Share	Get a 7-Day Free Trial															-0.21	-0.13	-0.11	-0.22	-0.22

Nutriband EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Nutriband's EBIT per Share for the fiscal year that ended in Jan. 2024 is calculated as

	EBIT per Share		(A: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5.409	/	7.954
=	-0.68

Nutriband's EBIT per Share for the quarter that ended in Jan. 2024 is calculated as

	EBIT per Share		(Q: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.858	/	8.317
=	-0.22

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.68

Nutriband (NAS:NTRB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Nutriband EBIT per Share Related Terms

Thank you for viewing the detailed overview of Nutriband's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nutriband (Nutriband) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (NAS:NTRB) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

9WV:Germany

Address

121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801

Website

https://www.nutriband.com

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Executives

Michael Davidov	director	60 EAST 42 STREET, NEW YORK NY 10165
Serguei Melnik	director, 10 percent owner, officer: Chief Financial Officer
Gareth Sheridan	director, 10 percent owner, officer: CEO	6064 CENTRAL COLLEGE RD., NEW ALBANY OH 43054
Vitalie Botgros	director, 10 percent owner, officer: Chairman of the BOD	GREGERSTR 36B, FISHAMEND C4 2401